GE HealthCare Technologies (GEHC) Cash & Equivalents (2022 - 2026)

GE HealthCare Technologies' Cash & Equivalents history runs 5 years deep, the most recent figure standing at $2.3 billion for Q1 2026.

• Quarterly Cash & Equivalents fell 7.71% year-over-year to $2.3 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2.3 billion (down 7.71% YoY) and the FY2025 annual result came in at $4.5 billion, up 55.96% from the prior year.
• Cash & Equivalents was $2.3 billion for Q1 2026 at GE HealthCare Technologies, down from $4.5 billion in the prior quarter.
• Across five years, Cash & Equivalents topped out at $4.5 billion in Q4 2025 and bottomed at $504.0 million in Q3 2022.
• A 5-year average of $2.4 billion and a median of $2.4 billion in 2023 frame the typical range for Cash & Equivalents.
• Annual changes were most pronounced in 2023 — Cash & Equivalents jumped 380.16% — and 2026, when it declined 7.71%.
• GE HealthCare Technologies' Cash & Equivalents stood at $1.5 billion in 2022, then jumped by 72.71% to $2.5 billion in 2023, then rose by 15.44% to $2.9 billion in 2024, then surged by 55.96% to $4.5 billion in 2025, then slumped by 49.36% to $2.3 billion in 2026.
• Business Quant data shows GEHC's Cash & Equivalents at $2.3 billion in Q1 2026, $4.5 billion in Q4 2025, and $4.0 billion in Q3 2025.